| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8833468 | Journal of the American College of Surgeons | 2018 | 28 Pages |
Abstract
One or more CTCs at baseline were associated with progression within 180 days in stage IV melanoma patients. This information warrants further study of CTCs as a means of identifying patients at high-risk for disease progression.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Carolyn S. PhD, Merrick MD, FACS, Jessica B. BA, Joshua BS, Mandar G. MBBS, MPH, Richard MD, FACS, Sapna MD, Anthony MD, FACS,